Shanghai Yizhong Pharmaceutical Co., Ltd. (SHA:688091)
China
· Delayed Price · Currency is CNY 54.95
+1.65 (3.10%)
Apr 29, 2026, 3:00 PM CST
SHA:688091 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Net Income | - | - | 6.98 | 161.55 | 142.85 | -4 | Upgrade
|
| Depreciation & Amortization | - | - | 11.16 | 7.88 | 6.43 | 6.59 | Upgrade
|
| Other Amortization | - | - | 0.7 | 0.3 | - | 0.56 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | - | -9.69 | -7.52 | -12.89 | -5.44 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | -5.06 | 5.43 | 2.03 | 0.22 | Upgrade
|
| Other Operating Activities | - | - | -12.97 | -26.94 | -18.33 | -5.81 | Upgrade
|
| Change in Accounts Receivable | - | - | 85 | -69.19 | -28.46 | -21.5 | Upgrade
|
| Change in Inventory | - | - | -16.73 | -11.38 | -5.28 | -10.3 | Upgrade
|
| Change in Accounts Payable | - | - | -17.4 | 30.42 | 17.72 | -3.81 | Upgrade
|
| Operating Cash Flow | - | - | 39.44 | 86.55 | 110.78 | -48.78 | Upgrade
|
| Operating Cash Flow Growth | - | - | -54.44% | -21.87% | - | - | Upgrade
|
| Capital Expenditures | - | - | -80.04 | -8.78 | -35.88 | -3.14 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | 0 | - | - | - | Upgrade
|
| Investment in Securities | - | - | -135 | 86 | 511.29 | -788.74 | Upgrade
|
| Other Investing Activities | - | - | 22.39 | 39.27 | 26.86 | 6.25 | Upgrade
|
| Investing Cash Flow | - | - | -192.65 | 116.49 | 502.27 | -785.63 | Upgrade
|
| Short-Term Debt Issued | - | - | 9.1 | 44 | - | 16.75 | Upgrade
|
| Total Debt Issued | - | - | 9.1 | 44 | - | 16.75 | Upgrade
|
| Short-Term Debt Repaid | - | - | -53.1 | - | -16.75 | -3.25 | Upgrade
|
| Total Debt Repaid | - | - | -53.1 | - | -16.75 | -3.25 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | -44 | 44 | -16.75 | 13.5 | Upgrade
|
| Issuance of Common Stock | - | - | 18.77 | - | - | 1,008 | Upgrade
|
| Repurchase of Common Stock | - | - | -37.24 | - | - | - | Upgrade
|
| Common Dividends Paid | - | - | -49.79 | -43.41 | -0.49 | - | Upgrade
|
| Other Financing Activities | - | - | - | - | - | -76.59 | Upgrade
|
| Financing Cash Flow | - | - | -112.27 | 0.59 | -17.24 | 944.65 | Upgrade
|
| Net Cash Flow | - | - | -265.48 | 203.64 | 595.82 | 110.24 | Upgrade
|
| Free Cash Flow | - | - | -40.6 | 77.77 | 74.9 | -51.93 | Upgrade
|
| Free Cash Flow Growth | - | - | - | 3.83% | - | - | Upgrade
|
| Free Cash Flow Margin | - | - | -23.40% | 21.59% | 31.74% | -1273.49% | Upgrade
|
| Free Cash Flow Per Share | - | - | -0.17 | 0.49 | 0.36 | -0.33 | Upgrade
|
| Cash Interest Paid | - | - | - | - | - | 0.59 | Upgrade
|
| Cash Income Tax Paid | - | - | 23.89 | 32.97 | -0.88 | 0.49 | Upgrade
|
| Levered Free Cash Flow | - | - | -30.3 | 55.22 | 33.72 | -50.68 | Upgrade
|
| Unlevered Free Cash Flow | - | - | -29.86 | 55.39 | 33.72 | -50.31 | Upgrade
|
| Change in Working Capital | - | - | 48.32 | -54.15 | -9.31 | -40.9 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.